CWF19L2 and breast carcinoma: In contrast, the expression levels of PIK3R1, PNPLA2, ATOH8, TTC23, and CWF19L2 were dramatically lower in breast cancer samples than in healthy controls (p < 0.05) (Figure 4H–L).